Photofrin

Photofrin Uses, Dosage, Side Effects, Food Interaction and all others data.

The purified component of hematoporphyrin derivative, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (hematoporphyrin photoradiation); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of photodynamic therapy in the United States.

Porfimer is a photosensitizing agent used in the photodynamic therapy (PDT) of tumors. Porfimer is indicated for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who cannot be satisfactorily treated with Nd:YAG laser therapy, reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial nonsmall cell lung cancer (NSCLC), and the treatment of microinvasive endobronchial NSCLC in patients for whom surgery and radiotherapy are not indicated. The cytotoxic and antitumor actions of porfimer are light and oxygen dependent. Tumor selectivity in treatment occurs through a combination of selective retention of porfimer and selective delivery of light.

Trade Name Photofrin
Generic Porfimer sodium
Porfimer sodium Other Names Porfimer natrium, Porfimer sodico, Porfimer sodium, Porfimère sodique, Porfimerum natricum
Weight 75mg,
Type Intravenous powder for injection
Protein binding

~90%

Groups Approved, Investigational
Therapeutic Class
Manufacturer Axcan Pharma Internacional, BV
Available Country Canada, United States, Portugal,
Last Updated: September 19, 2023 at 7:00 am
Photofrin
Photofrin

Uses

Photofrin is a hematoporphyrin derivative used to treat esophageal cancer, endobronchial cancer, and high grade dysplasia in Barrett's Esophagus.

Indicated in the treatment of esophageal cancer.

Photofrin is also used to associated treatment for these conditions: Esophageal Cancers, Esophagus, Barrett, Completely obstructive Non-small cell lung cancer, Microinvasive endobrachial Non-small cell lung cancer, Partially obstructive Non-small cell lung cancer

How Photofrin works

Cellular damage caused by porfimer is a consequence of the propagation of radical reactions. Radical initiation may occur after porfimer absorbs light to form a porphyrin excited state. Spin transfer from porfimer to molecular oxygen may then generate singlet oxygen. Subsequent radical reactions can form superoxide and hydroxyl radicals. Tumor death also occurs through ischemic necrosis secondary to vascular occlusion that appears to be partly mediated by thromboxane A2 release.

Food Interaction

No interactions found.

Volume of Distribution

  • 0.49 ± 0.28 L/kg [2 mg/kg dose of porfimer sodium to 4 male cancer patients]

Half Life

10-452 hours

Clearance

  • Renal cl=199.7 +/-  56.9 mL/min [Healthy subjects receiving a single 300-mg oral dose]

Innovators Monograph

You find simplified version here Photofrin

*** Taking medicines without doctor's advice can cause long-term problems.
Share